Firm Looks to Move Stem Cell Therapy to Mainstream Medicine

By: Dylan Sikes – AllPennyStocks.com News

Monday, August 1, 2022

Stem cell therapy holds much promise in helping the repair response of injured or diseased tissues and as patients search for a natural regenerative alternative without the potential risks and side effects sometimes associated with mainstream pharmaceuticals. alternative and elective procedures to mainstream protocols.

Biotechnology and Numismatics specialty company Meso Numismatics, Inc. (OTC: MSSV), announced additional global expansion by opening stem cell therapy and regenerative medicine facilities in Indonesia in its press release. The expansion will help Global Stem Cells Group's objective of introducing its therapies and technology to meet market demands in populous parts of the world.

Through strategic global networks, the firm looks delivers leadership in regenerative medicine research, patient applications, and training through our strategic global networks. The company is looking to enable physicians to treat otherwise incurable diseases using stem cell therapy.

Shares were trading up 4 percent in early afternoon trade.

Copyright © 2022 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.